NIH-funded research NIH-funded research

Understanding COVID-19 Immunity in Pregnant Mothers and Their Babies

Official title: SARS-CoV-2 in Pregnancy: Comparison of Natural Infection and Hybrid Immunity in Mother-Infant Pairs

Funded at University of California Los Angeles · NIH-11135473 · Data updated 2026-11-12

This project looks at how pregnant mothers and their babies develop protection against COVID-19, comparing natural infection with a combination of infection and vaccination.

More Pregnancy research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startJuly 5, 2023
Project endJune 30, 2028
Funding year2025
Award (this year)$203,580
NIH project number5K23AI177952-03
Project IDNIH-11135473 on NIH RePORTER

Who could benefit from this research

Could help

This project focuses on mother-infant pairs who experienced SARS-CoV-2 infection during pregnancy, some of whom also received COVID-19 vaccination.

Less likely to help

Patients who have not been pregnant or had SARS-CoV-2 infection during pregnancy would not directly benefit from participating in this specific project.

What this research studies

We want to learn more about how pregnant mothers and their babies build immunity to COVID-19. This project compares the immune responses from natural infection to those from a "hybrid immunity" which combines both infection and vaccination. We are especially interested in how this protection passes from mother to baby and lasts over time. This information will help us understand the long-term effects and the best ways to protect mothers and their infants from severe COVID-19.

Why it matters

Potential benefit: If successful, this work could help guide recommendations for vaccination strategies in pregnant individuals to better protect both mothers and their newborns from COVID-19.

How similar studies have gone: While previous studies have looked at natural infection or vaccine-induced immunity separately, this project explores the less understood area of hybrid immunity in pregnancy.

Where this research is happening

  • University of California Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Cambou, Mary Catherine — University of California Los Angeles
  • Study coordinator: Cambou, Mary Catherine

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.